ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31429-50mg |
|
1234844-11-1 |
GPR120 Agonist 2
|
0 | C22H25ClO4 | |
GC31429-10mg |
|
1234844-11-1 |
GPR120 Agonist 2
|
0 | C22H25ClO4 | |
GC31429-5mg |
|
1234844-11-1 |
GPR120 Agonist 2
|
0 | C22H25ClO4 | |
GC31429-10mM(1mLinDMSO) |
|
1234844-11-1 |
GPR120 Agonist 2
|
0 | C22H25ClO4 | |
GC31428-99mg |
|
704-15-4 |
H-Gly-Pro-OH
|
0 | C7H12N2O3 | |
GC31427-20mg |
|
69207-52-9 |
McN3716 (Methyl palmoxirate)
|
0 | C18H34O3 | |
GC31427-10mg |
|
69207-52-9 |
McN3716 (Methyl palmoxirate)
|
0 | C18H34O3 | |
GC31427-5mg |
|
69207-52-9 |
McN3716 (Methyl palmoxirate)
|
0 | C18H34O3 | |
GC31427-1mg |
|
69207-52-9 |
McN3716 (Methyl palmoxirate)
|
0 | C18H34O3 | |
GC31426-100mg |
|
135779-82-7 |
Bamaquimast (F 10126)
|
0 | C16H21N3O3 | |
GC31426-50mg |
|
135779-82-7 |
Bamaquimast (F 10126)
|
0 | C16H21N3O3 | |
GC31426-10mg |
|
135779-82-7 |
Bamaquimast (F 10126)
|
0 | C16H21N3O3 | |
GC31426-5mg |
|
135779-82-7 |
Bamaquimast (F 10126)
|
0 | C16H21N3O3 | |
GC31426-10mM(1mLinDMSO) |
|
135779-82-7 |
Bamaquimast (F 10126)
|
0 | C16H21N3O3 | |
GC31425-1mg |
|
80879-63-6 |
Emiglitate (BAY o 1248)
|
0 | C17H25NO7 | |
GC31424-50mg |
|
2190-30-9 |
Palmitodiolein (Triglyceride POO)
|
0 | C55H102O6 | |
GC31424-10mg |
|
2190-30-9 |
Palmitodiolein (Triglyceride POO)
|
0 | C55H102O6 | |
GC31423-5mg |
|
25518-54-1 |
Dodecanoylcarnitine
|
0 | C19H37NO4 | |
GC31423-10mM(1mLinDMSO) |
|
25518-54-1 |
Dodecanoylcarnitine
|
0 | C19H37NO4 | |
GC31422-10mg |
|
1039825-68-7 |
MCH-1 antagonist 1
|
0 | C25H26N4O2 | |